Emend (Aprepitant) is a moderately priced medication used to prevent nausea and vomiting caused by cancer treatment (chemotherapy). It is slightly more popular than comparable drugs. It is available in both brand and generic versions. The most common version of Emend is covered by 87% of insurance plans at a co-pay of $40.00-$60.00, however, some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.